Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. It engages in developing Realheart TAH to treat advanced stage heart failure. It also develops RealVAD, PulsePump, and Sternal Prosthesis products. The company was incorporated in 2007 and is based in Västerås, Sweden.
Stock data | 2024 | Change |
---|---|---|
Price | $0.021060880638683447 | N/A |
Market Cap | $2.04M | N/A |
Shares Outstanding | 96.99M | N/A |
Employees | 0 | N/A |